UY23239A1 - Procedimiento para la preparación de una forma medicinal inyectable retardada.- - Google Patents
Procedimiento para la preparación de una forma medicinal inyectable retardada.-Info
- Publication number
- UY23239A1 UY23239A1 UY23239A UY23239A UY23239A1 UY 23239 A1 UY23239 A1 UY 23239A1 UY 23239 A UY23239 A UY 23239A UY 23239 A UY23239 A UY 23239A UY 23239 A1 UY23239 A1 UY 23239A1
- Authority
- UY
- Uruguay
- Prior art keywords
- active substance
- substance
- mammal
- supporting
- diameter
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 230000003111 delayed effect Effects 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 4
- 241000124008 Mammalia Species 0.000 abstract 3
- 239000004005 microsphere Substances 0.000 abstract 3
- 239000000126 substance Substances 0.000 abstract 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
- Steroid Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9007417A FR2663224B1 (fr) | 1990-06-14 | 1990-06-14 | Forme galenique parenterale. |
Publications (1)
Publication Number | Publication Date |
---|---|
UY23239A1 true UY23239A1 (es) | 1991-07-12 |
Family
ID=9397599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY23239A UY23239A1 (es) | 1990-06-14 | 1991-06-13 | Procedimiento para la preparación de una forma medicinal inyectable retardada.- |
Country Status (33)
Country | Link |
---|---|
US (1) | US5643604A (bg) |
EP (1) | EP0487674B1 (bg) |
JP (1) | JP2690398B2 (bg) |
KR (1) | KR0157438B1 (bg) |
CN (1) | CN1058608C (bg) |
AT (1) | ATE117546T1 (bg) |
AU (1) | AU643540B2 (bg) |
BG (1) | BG61178B1 (bg) |
BR (1) | BR9105782A (bg) |
CA (1) | CA2064861C (bg) |
CZ (1) | CZ286199B6 (bg) |
DE (1) | DE69107026T2 (bg) |
DK (1) | DK0487674T3 (bg) |
ES (1) | ES2068592T3 (bg) |
FI (1) | FI107697B (bg) |
FR (1) | FR2663224B1 (bg) |
GR (1) | GR3015809T3 (bg) |
HU (1) | HU219461B (bg) |
IE (1) | IE69172B1 (bg) |
IL (1) | IL98458A (bg) |
NO (2) | NO920576L (bg) |
NZ (1) | NZ238543A (bg) |
PH (1) | PH30243A (bg) |
PL (1) | PL167177B1 (bg) |
PT (1) | PT97976B (bg) |
RO (1) | RO110198B1 (bg) |
RU (1) | RU2095055C1 (bg) |
SK (1) | SK279867B6 (bg) |
TN (1) | TNSN91047A1 (bg) |
TW (1) | TW205511B (bg) |
UY (1) | UY23239A1 (bg) |
WO (1) | WO1991019485A1 (bg) |
ZA (1) | ZA914549B (bg) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5981719A (en) | 1993-03-09 | 1999-11-09 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US6090925A (en) | 1993-03-09 | 2000-07-18 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US6416778B1 (en) | 1997-01-24 | 2002-07-09 | Femmepharma | Pharmaceutical preparations and methods for their regional administration |
US5993856A (en) * | 1997-01-24 | 1999-11-30 | Femmepharma | Pharmaceutical preparations and methods for their administration |
US6287693B1 (en) | 1998-02-25 | 2001-09-11 | John Claude Savoir | Stable shaped particles of crystalline organic compounds |
GB9819272D0 (en) * | 1998-09-03 | 1998-10-28 | Andaris Ltd | Microparticles |
PT1165044E (pt) | 1999-03-26 | 2004-10-29 | Pozen Inc | Composicoes de di-hidroergotamina de alta potencia |
DE50202200D1 (de) * | 2001-09-27 | 2005-03-17 | Cognis Deutschland Gmbh | Kugelförmige Sterinzubereitungen, deren Herstellung und Verwendung |
EP1448228A4 (en) * | 2001-10-24 | 2007-01-24 | Marco Pappagallo | TREATMENT OF POSTOPERATIVE PAIN |
CA2471400A1 (en) * | 2001-12-20 | 2003-07-03 | Femmepharma, Inc. | Vaginal delivery of drugs |
US7655618B2 (en) * | 2002-12-27 | 2010-02-02 | Diobex, Inc. | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
MXPA05006994A (es) * | 2002-12-27 | 2005-10-18 | Diobex Inc | Composiciones y metodos para la prevencion y el control de hipoglucemia inducida por insulina. |
US9173836B2 (en) | 2003-01-02 | 2015-11-03 | FemmeParma Holding Company, Inc. | Pharmaceutical preparations for treatments of diseases and disorders of the breast |
CA2511995C (en) * | 2003-01-02 | 2012-03-13 | Femmepharma Holding Company, Inc. | Pharmaceutical preparations for treatments of diseases and disorders of the breast |
EP1844765B1 (en) * | 2003-06-13 | 2015-01-21 | Skendi Finance, Ltd. | Slow release estradiol-progesterone formulation |
US7413690B1 (en) | 2003-10-29 | 2008-08-19 | The University Of Mississippi | Process and apparatus for producing spherical pellets using molten solid matrices |
ATE511512T1 (de) | 2005-01-05 | 2011-06-15 | Lilly Co Eli | Olanzapinpamoat-dihydrat |
WO2007072491A2 (en) * | 2005-12-21 | 2007-06-28 | Baskaran Chandrasekar | Sustained release pharmaceutical formulation and treatment of ischemic heart disease by administering the same |
US8431593B2 (en) | 2006-11-27 | 2013-04-30 | H. Lundbeck A/S | Heteroaryl amide derivatives |
WO2008083158A2 (en) * | 2006-12-26 | 2008-07-10 | Femmepharma Holding Company, Inc. | Topical administration of danazol |
CN102056611A (zh) * | 2008-04-14 | 2011-05-11 | Posi维森纳里解决方案有限责任公司 | 用于获得不同的治疗适应症所需要的血浆孕酮水平的方法和药物组合物 |
US20110003000A1 (en) * | 2009-07-06 | 2011-01-06 | Femmepharma Holding Company, Inc. | Transvaginal Delivery of Drugs |
UY33103A (es) | 2009-12-15 | 2011-07-29 | Techsphere S A De C V | Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico |
HUE027298T2 (en) * | 2010-01-14 | 2016-10-28 | Asarina Pharma Ab | Pharmaceutical composition containing developed storage and dissolution properties containing 3-beta-hydroxy-5-alpha-pregnan-20-one |
RU2576236C1 (ru) * | 2014-08-22 | 2016-02-27 | Александр Александрович Кролевец | Способ получения нанокапсул антибиотиков в агар-агаре |
RU2577689C1 (ru) * | 2014-08-26 | 2016-03-20 | Александр Александрович Кролевец | Способ получения нанокапсул антибиотиков в агар-агаре |
RU2578408C1 (ru) * | 2014-09-10 | 2016-03-27 | Александр Александрович Кролевец | Способ получения нанокапсул алкалоидов |
ITUB20153652A1 (it) * | 2015-09-16 | 2017-03-16 | Fatro Spa | Microsfere contenenti lattoni macrociclici antielminitici |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE744162A (fr) * | 1969-01-16 | 1970-06-15 | Fuji Photo Film Co Ltd | Procede d'encapsulage |
US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
US3937668A (en) * | 1970-07-15 | 1976-02-10 | Ilse Zolle | Method for incorporating substances into protein microspheres |
DK123067B (da) * | 1970-09-25 | 1972-05-15 | Niro Atomizer As | Fremgangsmåde til behandling af et pulverformigt, fedtholdigt mælkeprodukt. |
JPS5017525A (bg) * | 1973-06-14 | 1975-02-24 | ||
US3982537A (en) * | 1974-12-30 | 1976-09-28 | Louis Bucalo | Dynamic implants and method for implanting the same |
CA1077842A (en) * | 1975-10-09 | 1980-05-20 | Minnesota Mining And Manufacturing Company | Albumin medicament carrier system |
IT1202370B (it) * | 1976-07-12 | 1989-02-09 | Hoffmann La Roche | Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti |
US4357259A (en) * | 1977-08-01 | 1982-11-02 | Northwestern University | Method of incorporating water-soluble heat-sensitive therapeutic agents in albumin microspheres |
US4244949A (en) * | 1978-04-06 | 1981-01-13 | The Population Council, Inc. | Manufacture of long term contraceptive implant |
US4384975A (en) * | 1980-06-13 | 1983-05-24 | Sandoz, Inc. | Process for preparation of microspheres |
US4331654A (en) * | 1980-06-13 | 1982-05-25 | Eli Lilly And Company | Magnetically-localizable, biodegradable lipid microspheres |
US4349530A (en) * | 1980-12-11 | 1982-09-14 | The Ohio State University | Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal |
FR2524312B1 (fr) * | 1982-04-01 | 1985-10-04 | Tech Cuir Centre | Nouvelles formes de micro-encapsulation de substances medicamenteuses par des couches homogenes de collagene natif |
US4492720A (en) * | 1983-11-15 | 1985-01-08 | Benjamin Mosier | Method of preparing microspheres for intravascular delivery |
US4963367A (en) * | 1984-04-27 | 1990-10-16 | Medaphore, Inc. | Drug delivery compositions and methods |
JPS61174940A (ja) * | 1985-01-29 | 1986-08-06 | Oogawara Kakoki Kk | ワックス類コーテイング単核状マイクロカプセルおよびその製造方法 |
US4675173A (en) * | 1985-05-08 | 1987-06-23 | Molecular Biosystems, Inc. | Method of magnetic resonance imaging of the liver and spleen |
IL79407A (en) * | 1985-08-01 | 1991-03-10 | Theragenics Corp | System and method for delivering insoluble material into a living body |
EP0257368B1 (en) * | 1986-08-11 | 1992-03-25 | American Cyanamid Company | Compositions for parenteral administration and their use |
US4837381A (en) * | 1986-08-11 | 1989-06-06 | American Cyanamid Company | Compositions for parenteral administration and their use |
CA1319886C (en) * | 1987-02-03 | 1993-07-06 | Alberto Ferro | Mixed micelle solutions |
US4748024A (en) | 1987-04-06 | 1988-05-31 | Endocon, Inc. | Flash flow fused medicinal implants |
US4892734A (en) * | 1987-04-06 | 1990-01-09 | Endocon, Inc. | Dispensing paste for forming medicinal pellets |
ATE109941T1 (de) * | 1987-04-06 | 1994-09-15 | Endocon Inc | Durch schnellschmelzen hergestellte medizinische implantate. |
AU4369589A (en) * | 1988-10-27 | 1990-05-03 | Abbott Laboratories | Controlled-release delivery device, method for producing device, and method of using device |
US5019400A (en) * | 1989-05-01 | 1991-05-28 | Enzytech, Inc. | Very low temperature casting of controlled release microspheres |
US5085864A (en) * | 1989-10-30 | 1992-02-04 | Abbott Laboratories | Injectable formulation for lipophilic drugs |
FR2663223B1 (fr) * | 1990-06-14 | 1994-12-02 | Af Aplicaciones Far Lab | Forme galenique parenterale. |
-
1990
- 1990-06-14 FR FR9007417A patent/FR2663224B1/fr not_active Expired - Fee Related
-
1991
- 1991-06-11 IL IL9845891A patent/IL98458A/en not_active IP Right Cessation
- 1991-06-12 RO RO92-200136A patent/RO110198B1/ro unknown
- 1991-06-12 RU SU915011663A patent/RU2095055C1/ru active
- 1991-06-12 EP EP91910873A patent/EP0487674B1/fr not_active Expired - Lifetime
- 1991-06-12 ES ES91910873T patent/ES2068592T3/es not_active Expired - Lifetime
- 1991-06-12 CA CA002064861A patent/CA2064861C/fr not_active Expired - Fee Related
- 1991-06-12 DK DK91910873.8T patent/DK0487674T3/da active
- 1991-06-12 HU HU9200775A patent/HU219461B/hu not_active IP Right Cessation
- 1991-06-12 BR BR919105782A patent/BR9105782A/pt not_active Application Discontinuation
- 1991-06-12 DE DE69107026T patent/DE69107026T2/de not_active Expired - Fee Related
- 1991-06-12 WO PCT/EP1991/001097 patent/WO1991019485A1/fr active IP Right Grant
- 1991-06-12 JP JP3510713A patent/JP2690398B2/ja not_active Expired - Lifetime
- 1991-06-12 AU AU80667/91A patent/AU643540B2/en not_active Ceased
- 1991-06-12 AT AT91910873T patent/ATE117546T1/de not_active IP Right Cessation
- 1991-06-12 KR KR1019920700315A patent/KR0157438B1/ko not_active IP Right Cessation
- 1991-06-13 IE IE201891A patent/IE69172B1/en not_active IP Right Cessation
- 1991-06-13 SK SK1815-91A patent/SK279867B6/sk unknown
- 1991-06-13 UY UY23239A patent/UY23239A1/es not_active IP Right Cessation
- 1991-06-13 CZ CS19911815A patent/CZ286199B6/cs not_active IP Right Cessation
- 1991-06-14 PT PT97976A patent/PT97976B/pt not_active IP Right Cessation
- 1991-06-14 TN TNTNSN91047A patent/TNSN91047A1/fr unknown
- 1991-06-14 NZ NZ238543A patent/NZ238543A/en not_active IP Right Cessation
- 1991-06-14 PL PL91290678A patent/PL167177B1/pl not_active IP Right Cessation
- 1991-06-14 TW TW080104715A patent/TW205511B/zh active
- 1991-06-14 ZA ZA914549A patent/ZA914549B/xx unknown
- 1991-06-14 CN CN91104858A patent/CN1058608C/zh not_active Expired - Fee Related
- 1991-06-14 PH PH42634A patent/PH30243A/en unknown
-
1992
- 1992-02-13 NO NO92920576A patent/NO920576L/no unknown
- 1992-02-13 NO NO920576A patent/NO302927B1/no not_active IP Right Cessation
- 1992-02-13 BG BG95911A patent/BG61178B1/bg unknown
- 1992-02-14 FI FI920661A patent/FI107697B/fi active
-
1993
- 1993-07-14 US US08/094,579 patent/US5643604A/en not_active Expired - Lifetime
-
1995
- 1995-04-17 GR GR950400939T patent/GR3015809T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY23239A1 (es) | Procedimiento para la preparación de una forma medicinal inyectable retardada.- | |
BRPI0516308A2 (pt) | composição fluida, métodos de tratamento de uma doença ou disfunção, métodos de liberação local ou sistêmica de um agente biológico, implantes, método de formação de um implante, kit de agente biológico e usos de uma composição fluida | |
Smith | Evaluation of poly (lactic acid) as a biodegradable drug delivery system for parenteral administration | |
CA1127966A (en) | Pharmaceutical vehicle | |
CA2085344A1 (en) | Injectable Pharmaceutical Composition | |
CN101437478A (zh) | 聚合送递制剂的眼部送递 | |
KR20070059161A (ko) | 도파민 수용체 효능제를 함유하는 장시간 작용 서방성 제제및 그 제조방법 | |
PT98497B (pt) | Processo para a preparacao de particulas para a libertacao controlada de um ingrediente activo | |
KR102507678B1 (ko) | 아리피프라졸 서방형 미소구체 및 이의 제조 방법 | |
EP2088962A4 (en) | OPTIMIZED SHEATH FOR STENT | |
KR920009385A (ko) | 서방성 안구삽입용 약제 | |
JPH02117A (ja) | 活性物質放出用の埋込可能な生分解性組成物 | |
Agrahari et al. | Electrospun nanofibers in drug delivery: fabrication, advances, and biomedical applications | |
Xie et al. | A new strategy to sustained release of ocular drugs by one-step drug-loaded microcapsule manufacturing in hydrogel punctal plugs | |
Pei et al. | Application of sustained delivery microsphere of cyclosporine A for preventing posterior capsular opacification in rabbits | |
ES2066062T3 (es) | Preparacion de liberacion sostenida para administracion al cerebro. | |
WO2021087408A1 (en) | Otic formulations for drug-induced ototoxicity | |
DE69113976D1 (de) | Verfahren zur galenischen herstellung eines therapeutischen mittels, insbesondere auf aspirinbasis. | |
Agarwal et al. | Dexamethasone loaded electrospun nanocomposite ocular insert: in-vitro drug release and mechanical assessment | |
KR20070038737A (ko) | 성장인자가 함유된 나노입자가 코팅된 마이크로스피어의제조 및 이의 신경분화로의 이용 방법 | |
KR102404224B1 (ko) | 성호르몬계 약물을 포함하는 생분해성 고분자 미세입자 및 이의 제조 방법 | |
Tamaddon et al. | Development, characterizations and biocompatibility evaluations of intravitreal lipid implants | |
Shiverick et al. | Drugs and the placenta—A workshop report | |
HUE030248T2 (en) | controlled release formulation containing hCG | |
CN101601660A (zh) | 一种含氯吡格雷的可溶片剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
VENC | Patent expired |
Effective date: 20140527 |